Goldman Sachs Group Inc Epizyme, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 14, 2024
BUY
$0.42 - $1.48 $1.1 Million - $3.89 Million
2,629,998 New
2,629,998 $3.87 Million
Q2 2022

Aug 15, 2022
SELL
$0.42 - $1.48 $1.31 Million - $4.61 Million
-3,112,142 Reduced 54.2%
2,629,998 $3.87 Million
Q1 2022

May 16, 2022
BUY
$1.06 - $2.68 $2.63 Million - $6.65 Million
2,479,597 Added 76.0%
5,742,140 $6.6 Million
Q4 2021

Feb 14, 2022
BUY
$2.5 - $5.19 $6.73 Million - $14 Million
2,690,437 Added 470.27%
3,262,543 $8.16 Million
Q3 2021

Nov 10, 2021
BUY
$4.82 - $8.46 $2.76 Million - $4.84 Million
572,106 New
572,106 $2.93 Million

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email